Local Anesthetic As Safe As General Anesthetic for TAVR

Share this content:
Local Anesthetic As Safe As General Anesthetic for TAVR
Local Anesthetic As Safe As General Anesthetic for TAVR

MONDAY, Nov. 21, 2016 (HealthDay News) -- For patients undergoing transcatheter aortic valve replacement (TAVR), local anesthetic (LA) is as safe as general anesthetic (GA), with shorter procedure time and number of days in the hospital, according to a study published in the Dec. 1 issue of The American Journal of Cardiology.

Avais Jabbar, M.B.B.S., from the Freeman Hospital in Newcastle Upon Tyne, U.K., and colleagues described their experience in patients undergoing TAVR under LA who were subsequently transferred to a low dependency unit. Overall, 145 patients had the TAVR procedure under GA and 71 under LA.

The researchers found that the procedure time, as measured from time in room to skin closure, was significantly shorter in the LA group (108 versus 143 minutes; P < 0.001). Skin open to skin closure time did not differ between the groups (78 versus 79.4 minutes; P = 0.57). No differences were seen between the groups in 30-day: aortic regurgitation > mild (P = 0.67), need for permanent pacing (P = 0.32), and disabling cerebrovascular accidents (P = 1.0). There was no significant difference in 30-day survival (95.9 percent in GA versus 100 percent in LA; P = 0.17), while the LA group had a significantly shorter number of days in the hospital (two, versus four in the GA group; P < 0.001). The LA group had no emergency conversions to GA; only one patient required admission to a high dependency unit.

"In conclusion, performing a TAVR under LA is at least as safe as GA," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »